[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.249.135. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1984

Ocular Pharmacokinetics of Ceftriaxone Following Subconjunctival Injection in Rabbits

Author Affiliations

From the Department of Ophthalmology (Drs Jay, A. M. Aziz, and M. Z. Aziz) and the Division of Infectious Disease (Drs Shockley and Rissing), Veterans Administration Medical Center, and the Medical College of Georgia, Augusta.

Arch Ophthalmol. 1984;102(3):430-432. doi:10.1001/archopht.1984.01040030344034
Abstract

• Aqueous and vitreous kinetics were studied after anterior subconjunctival injection of 100 mg of ceftriaxone sodium in phakic and aphakic rabbit eyes. Mean peak ceftriaxone concentrations (microgram per milliliter ± SE, n = 3 to 5 rabbits per determination) were as follows: phakic eyes, 159.5 ± 42 at one hour in aqueous humor and 25.3 ± 6.6 at two hours in vitreous fluid; aphakic eyes, 105.1 ± 20.5 at one hour in aqueous humor and 43.1 ± 15.4 at one hour in vitreous humor. The ability of ceftriaxone to eliminate an incipient bacterial infection was also evaluated. Ten aphakic rabbits were challenged intravitreally with 700 colony-forming units of Staphylococcus aureus. Six of the ten immediately received subconjunctival injections of ceftriaxone sodium (100 mg). At 48 hours following the challenge, all four control eyes yielded greater than 5.6 × 105 colonies per milliliter. In the six eyes receiving ceftriaxone, five were sterile and one yielded 1.4 × 102 colonies per milliliter.

References
1.
Puliafito CA, Baker AS, Haaf J, et al:  Infectious endophthalmitis: Review of 36 cases . Ophthalmology 1982;89:921-929.Article
2.
Ellis PP: Ocular Therapeutics and Pharmacology . St Louis, CV Mosby Co, 1981, pp 162-172.
3.
Pearlman MD:  Prophylactic subconjunctival penicillin and streptomycin after cataract extraction . Arch Ophthalmol 1956;55:516-518.Article
4.
Chalkley THF, Shoch D:  An evaluation of prophylactic subconjunctival antibiotic injection in cataract surgery . Am J Ophthalmol 1967; 64:1084-1087.
5.
Baum JL, Peyman GA:  Antibiotic administration in the treatment of bacterial endophthalmitis . Surv Ophthalmol 1977;21:332-346.
6.
Barza M:  Factors affecting the intraocular penetration of antibiotics . Scand J Infect Dis 1978;14( (suppl) ):151-159.
7.
Gnann JW, Goetter WE, Elliott AM, et al:  Ceftriaxone: In vitro studies and clinical evaluation . Antimicrob Agents Chemother 1982;22:1-9.Article
8.
Beskid G, Christenson JG, Cleeland R, et al:  In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin . Antimicrob Agents Chemother 1981;20:159-167.Article
9.
Bradsher RW:  Ceftriaxone (Ro 13-9904) therapy of serious infection . Antimicrob Agents Chemother 1982;22:36-42.Article
10.
Maslow MJ, Levine JF, Pollock AA, et al:  Efficacy of a 12-hourly ceftriaxone regimen in the treatment of serious bacterial infections . Antimicrob Agents Chemother 1982;22:103-107.Article
11.
Draize JH, Woodard G, Calvery HO:  Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes . J Pharmacol Exp Ther 1944; 82:377-390.
12.
Abel R, Boyle GL:  Dissecting ocular tissue for intraocular drug studies . Invest Ophthalmol 1976;15:216-219.
13.
Sabath LD, Matsen JM:  Assay of antimicrobial agents , in Lennette EH, Spaulding EH, Truant JP (eds): Manual of Clinical Microbiology. Washington , DC, American Society for Microbiology, 1974, pp 428-430.
14.
Mirate DJ, Morgan TR, Green K, et al:  A simple technique for extracapsular lens extraction in the rabbit . Curr Eye Res 1981;1:491-493.Article
15.
Barza M, Kane A, Baum JL:  Intraocular levels of cefamandole compared with cefazolin after subconjunctival injection in rabbits . Invest Ophthalmol Vis Sci 1979;18:250-255.
16.
Saunders JH, McPherson SD:  Ocular penetration of cefazolin in humans and rabbits after subconjunctival injection . Am J Ophthalmol 1980; 89:564-566.
17.
Eickoff TC, Ehret J:  Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative . Antimicrob Agents Chemother 1981;19:435-442.Article
18.
Shannon K, King A, Warren C, et al:  In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases . Antimicrob Agents Chemother 1980;18:292-298.Article
19.
Greenwood D, Eley A:  Activity of a new cephalosporin antibiotic Ro 13-9904, against dense populations of selected enterobacteria . Antimicrob Agents Chemother 1981;19:66-71.Article
20.
Kane A, Barza M, Baum J:  Penetration of ocular tissues and fluids by moxalactam in rabbits with staphylococcal endophthalmitis . Antimicrob Agents Chemother 1981;20:595-599.Article
21.
Leeds NH, Peyman GA, House B:  Moxalactam (Moxam) in the treatment of experimental staphylococcal endophthalmitis . Ophthalmic Surg 1982;13:653-656.
×